15993441|t|Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro.
15993441|a|The data we present here suggest that agonists of peroxisome proliferator-activated receptor-gamma (PPARgamma) can attenuate the effects of beta-amyloid peptide (Abeta). Alzheimer's disease is associated with elevated levels of Abeta, and enhanced expression of PPARgamma. In this study, we determined that application of Abeta([1-40]) could impair hippocampal post-tetanic potentiation (PTP) and long-term potentiation (LTP) in vitro. We investigated the effects of PPARgamma agonists; troglitazone, ciglitazone and 15-deoxy-delta(12,14) prostaglandin J2 (PGJ2) on synaptic transmission and plasticity in area CA1. Both ciglitazone and PGJ2 increased baseline synaptic transmission significantly, without altering paired-pulse facilitation. PGJ2 produced a significant reduction in LTP, whereas ciglitazone and troglitazone had no significant effect. In addition, prior application of each ligand attenuated the previously observed Abeta([1-40])-mediated impairment of LTP. The effect of troglitazone on the Abeta([1-40])-mediated impairment of LTP was not reversed by the PPARgamma antagonist, GW-9662. These findings demonstrate that PPARgamma agonists attenuate the effects of Abeta on LTP, and support the potential use of these agents to alleviate the symptoms of Alzheimer's disease. We also suggest that PPARgamma agonists may regulate expression of hippocampal LTP in vitro.
15993441	12	60	peroxisome proliferator-activated receptor-gamma	Gene	5468
15993441	75	80	Abeta	Gene	351
15993441	187	235	peroxisome proliferator-activated receptor-gamma	Gene	5468
15993441	237	246	PPARgamma	Gene	5468
15993441	277	297	beta-amyloid peptide	Gene	351
15993441	299	304	Abeta	Gene	351
15993441	307	326	Alzheimer's disease	Disease	MESH:D000544
15993441	365	370	Abeta	Gene	351
15993441	399	408	PPARgamma	Gene	5468
15993441	459	464	Abeta	Gene	351
15993441	604	613	PPARgamma	Gene	5468
15993441	624	636	troglitazone	Chemical	MESH:D000077288
15993441	638	649	ciglitazone	Chemical	MESH:C039671
15993441	654	692	15-deoxy-delta(12,14) prostaglandin J2	Chemical	MESH:C097240
15993441	694	698	PGJ2	Chemical	MESH:C037112
15993441	758	769	ciglitazone	Chemical	MESH:C039671
15993441	774	778	PGJ2	Chemical	MESH:C037112
15993441	879	883	PGJ2	Chemical	MESH:C037112
15993441	933	944	ciglitazone	Chemical	MESH:C039671
15993441	949	961	troglitazone	Chemical	MESH:D000077288
15993441	1070	1075	Abeta	Gene	351
15993441	1126	1138	troglitazone	Chemical	MESH:D000077288
15993441	1146	1151	Abeta	Gene	351
15993441	1211	1220	PPARgamma	Gene	5468
15993441	1233	1240	GW-9662	Chemical	MESH:C457499
15993441	1274	1283	PPARgamma	Gene	5468
15993441	1318	1323	Abeta	Gene	351
15993441	1407	1426	Alzheimer's disease	Disease	MESH:D000544
15993441	1449	1458	PPARgamma	Gene	5468
15993441	Negative_Correlation	MESH:D000077288	351
15993441	Positive_Correlation	MESH:D000077288	5468
15993441	Positive_Correlation	MESH:D000544	351
15993441	Negative_Correlation	MESH:C457499	5468
15993441	Negative_Correlation	351	5468
15993441	Positive_Correlation	MESH:C037112	5468
15993441	Positive_Correlation	MESH:D000544	5468
15993441	Positive_Correlation	MESH:C097240	5468
15993441	Positive_Correlation	MESH:C039671	5468
15993441	Negative_Correlation	MESH:C457499	MESH:D000077288

